Iovance Biotherapeutics, Inc.
USD4.21
-0.04 (-0.94%)
CEO
Frederick G. Vogt
IPO Date
2010-10-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.33
Prev. Close
$4.25
Day Low
$4.17
Day High
$4.46
52W Low
$1.67
52W High
$5.63
Market Cap
$1.51B
Volume
10.61M
| -5.8 |
| 31 Dec 2023 | FY | -804.5% | -37345.4% | -76.0% | -56.9% | 0.13 | 2.79 | -4.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -79.2% | -59.6% | 0.17 | 5.24 | -2.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -55.1% | -44.0% | 0.12 | 5.69 | -8.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -39.5% | -33.8% | 0.08 | 11.59 | -24.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -66.1% | -57.3% | 0.04 | 8.10 | -17.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -26.5% | -25.7% | 0.00 | 33.02 | -7.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -63.3% | -59.3% | 0.00 | 15.09 | -5.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -31.7% | -30.8% | 0.00 | 34.12 | -7.3 |
| -3.9 |
| 30 Sept 2025 | Q3 | 97.9% | -135.3% | -13.0% | -10.1% | 0.07 | 3.41 | -2.2 |
| 30 Jun 2025 | Q2 | 5.5% | -186.2% | -16.0% | -12.3% | 0.08 | 3.27 | -1.3 |
| 31 Mar 2025 | Q1 | -0.8% | -235.5% | -15.1% | -12.0% | 0.07 | 4.18 | -2.3 |
| 31 Dec 2024 | Q4 | 38.2% | -106.6% | -11.1% | -8.6% | 0.08 | 3.74 | -7.2 |
| 30 Sept 2024 | Q3 | 32.0% | -142.7% | -10.8% | -8.4% | 0.10 | 4.22 | -8.5 |
| 30 Jun 2024 | Q2 | -0.8% | -312.2% | -12.6% | -10.1% | 0.11 | 5.15 | -5.9 |
| 31 Mar 2024 | Q1 | -915.5% | -15800.8% | -16.6% | -13.0% | 0.12 | 4.63 | -8.4 |
| 31 Dec 2023 | Q4 | -805.6% | -24145.0% | -19.9% | -14.9% | 0.13 | 2.79 | -4.5 |